Shenzhen Beirunniu Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Beirunniu Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include QUORVUS. The owner is based in Shenzhen, Guangdong.

Pinghu Community, Pinghu Street, Longgang District

11B, Fengguan Huating, No. 253 Fenghuang Avenue

Shenzhen, Guangdong 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

QUORVUS
QUORVUS
Registered 2025

Trademark Classifications

Shenzhen Beirunniu Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Beirunniu Technology Co., Ltd. have?

Shenzhen Beirunniu Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Beirunniu Technology Co., Ltd. file in?

Shenzhen Beirunniu Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhen Beirunniu Technology Co., Ltd.'s most well-known trademarks?

Shenzhen Beirunniu Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as QUORVUS. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Beirunniu Technology Co., Ltd.'s trademark registration success rate?

Shenzhen Beirunniu Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.